BG
EW icon

BDF Gestion’s Edwards Lifesciences EW Stock Holding History

BDF Gestion’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-34,524
Closed -$2.94M – 150
2025
Q4 		$2.94M Sell
34,524
-2,301
-6% -$189K 0.36% 72
2025
Q3 		$2.86M Sell
36,825
-7,658
-17% -$598K 0.34% 76
2025
Q2 		$3.48M Sell
44,483
-4,847
-10% -$361K 0.39% 65
2025
Q1 		$3.58M Hold
49,330
– – 0.39% 67
2024
Q4 		$3.65M Sell
49,330
-6,406
-11% -$448K 0.37% 68
2024
Q3 		$3.01M Hold
55,736
– – 0.32% 82
2024
Q2 		$5.15M Buy
+55,736
New +$4.94M 0.5% 48

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

BDF Gestion's EW Position: Q1 2026 in Review

BDF Gestion sold out of Edwards Lifesciences (EW) in Q1 2026, closing a stake of 34,524 shares — an estimated $2.94M sold.

BDF Gestion first reported a position in EW in Q2 2024 and held it in 7 quarters. The position peaked at $5.15M in Q2 2024. 1,291 funds tracked by Wall St. Rank hold EW as of Q1 2026.

  • BDF Gestion reported no remaining Edwards Lifesciences position as of Q1 2026 after selling out during the quarter.
  • BDF Gestion sold 34,524 Edwards Lifesciences shares in Q1 2026, an estimated $2.94M.
  • BDF Gestion first reported a position in Edwards Lifesciences in Q2 2024 and held it in 7 quarters.
  • BDF Gestion's Edwards Lifesciences position peaked at $5.15M in Q2 2024.
  • 1,291 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2026.

Based on BDF Gestion's 13F filing for Q1 2026, filed 10 Apr 2026.